{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:37:24Z","timestamp":1791488244399,"version":"4.3.4"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>In recent years, the development of diagnostics using artificial intelligence (AI) has been remarkable. AI algorithms can go beyond human reasoning and build diagnostic models from a number of complex combinations. Using next-generation sequencing technology, we identified hepatitis C virus (HCV) variants resistant to directing-acting antivirals (DAA) by whole genome sequencing of full-length HCV genomes, and applied these variants to various machine-learning algorithms to evaluate a preliminary predictive model. HCV genomic RNA was extracted from serum from 173 patients (109 with subsequent sustained virological response [SVR] and 64 without) before DAA treatment. HCV genomes from the 109 SVR and 64 non-SVR patients were randomly divided into a training data set (57 SVR and 29 non-SVR) and a validation-data set (52 SVR and 35 non-SVR). The training data set was subject to nine machine-learning algorithms selected to identify the optimized combination of functional variants in relation to SVR status following DAA therapy. Subsequently, the prediction model was tested by the validation-data set. The most accurate learning method was the support vector machine (SVM) algorithm (validation accuracy, 0.95; kappa statistic, 0.90; F-value, 0.94). The second-most accurate learning algorithm was Multi-layer perceptron. Unfortunately, Decision Tree, and Naive Bayes algorithms could not be fitted with our data set due to low accuracy (&lt; 0.8). Conclusively, with an accuracy rate of 95.4% in the generalization performance evaluation, SVM was identified as the best algorithm. Analytical methods based on genomic analysis and the construction of a predictive model by machine-learning may be applicable to the selection of the optimal treatment for other viral infections and cancer.<\/jats:p>","DOI":"10.1371\/journal.pone.0242028","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T18:54:28Z","timestamp":1604602468000},"page":"e0242028","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["A machine learning-based treatment prediction model using whole genome variants of hepatitis C virus"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-1837","authenticated-orcid":true,"given":"Hiroaki","family":"Haga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Koseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Okumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Hoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Nishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5623-4250","authenticated-orcid":true,"given":"Yoshiyuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"issue":"6","key":"pone.0242028.ref001","first-page":"76","article-title":"Artificial Intelligence Use in Healthcare Growing Fast","volume":"88","year":"2017","journal-title":"J AHIMA"},{"issue":"4","key":"pone.0242028.ref002","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/svn-2017-000101","article-title":"Artificial intelligence in healthcare: past, present and future","volume":"2","author":"F Jiang","year":"2017","journal-title":"Stroke Vasc Neurol"},{"issue":"7553","key":"pone.0242028.ref003","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"Y LeCun","year":"2015","journal-title":"Nature"},{"issue":"6963","key":"pone.0242028.ref004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature02099","article-title":"An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus","volume":"426","author":"D Lamarre","year":"2003","journal-title":"Nature"},{"issue":"1","key":"pone.0242028.ref005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens","volume":"151","author":"JM Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"pone.0242028.ref006","first-page":"261","article-title":"Hepatitis C virus population dynamics during infection","volume":"299","author":"JM Pawlotsky","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"pone.0242028.ref007","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1128\/JVI.76.8.4008-4021.2002","article-title":"Persistent and transient replication of full-length hepatitis C virus genomes in cell culture","volume":"76","author":"T Pietschmann","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"pone.0242028.ref008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-5793(91)80322-T","article-title":"Molecular structure of the Japanese hepatitis C viral genome","volume":"280","author":"N Kato","year":"1991","journal-title":"FEBS Lett"},{"issue":"19","key":"pone.0242028.ref009","doi-asserted-by":"crossref","first-page":"16741","DOI":"10.1074\/jbc.M212602200","article-title":"Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase","volume":"278","author":"JA Grobler","year":"2003","journal-title":"J Biol Chem"},{"issue":"9","key":"pone.0242028.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024907","article-title":"Genetic Heterogeneity of Hepatitis C Virus in Association with Antiviral Therapy Determined by Ultra-Deep Sequencing","volume":"6","author":"A Nasu","year":"2011","journal-title":"Plos One"},{"key":"pone.0242028.ref011","article-title":"A method for near full-length amplification and sequencing for six hepatitis C virus genotypes","volume":"17","author":"RA Bull","year":"2016","journal-title":"Bmc Genomics"},{"issue":"14","key":"pone.0242028.ref012","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"3","key":"pone.0242028.ref013","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"B Langmead","year":"2009","journal-title":"Genome Biol"},{"issue":"4","key":"pone.0242028.ref014","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/hepr.12980","article-title":"Retreatment with sofosbuvir\/ledipasvir with or without lead-in interferon-beta injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir\/asunaprevir therapy","volume":"48","author":"H Uemura","year":"2018","journal-title":"Hepatol Res"},{"issue":"18","key":"pone.0242028.ref015","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1128\/JVI.02326-07","article-title":"A hepatitis C virus cis-acting replication element forms a long-range RNA-RNA interaction with upstream RNA sequences in NS5B","volume":"82","author":"S Diviney","year":"2008","journal-title":"J Virol"},{"key":"pone.0242028.ref016","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.antiviral.2014.05.015","article-title":"Update on hepatitis C virus resistance to direct-acting antiviral agents","volume":"108","author":"E Poveda","year":"2014","journal-title":"Antiviral Res"},{"key":"pone.0242028.ref017","doi-asserted-by":"crossref","first-page":"S473","DOI":"10.1016\/S0168-8278(12)61205-7","article-title":"A Description of Virologic Escape in Hcv Genotype 1-Infected Patients Treated with Daclatasvir (Bms-790052) in Combination with Ribavirin and Peginterferon Alfa-2a or Peginterferon Alfa-2b","volume":"56","author":"F McPhee","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0242028.ref018","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1473-3099(15)70099-X","article-title":"Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial","volume":"15","author":"M Mizokami","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"pone.0242028.ref019","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00535-018-1473-z","article-title":"Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection","volume":"53","author":"H Toyoda","year":"2018","journal-title":"Japan. J Gastroenterol"},{"issue":"7","key":"pone.0242028.ref020","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00535-019-01561-1","article-title":"Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience","volume":"54","author":"Y Ueda","year":"2019","journal-title":"J Gastroenterol"},{"issue":"1","key":"pone.0242028.ref021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00535-018-1503-x","article-title":"Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial","volume":"54","author":"T Takehara","year":"2019","journal-title":"J Gastroenterol"},{"issue":"1","key":"pone.0242028.ref022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/jgh.13587","article-title":"Effectiveness and safety of daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: Systematic review and meta-analysis","volume":"32","author":"HL Wang","year":"2017","journal-title":"J Gastroenterol Hepatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0242028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T18:54:41Z","timestamp":1604602481000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0242028"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Kanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0242028","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}